Month July 2021

FDA Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue-based products

The US FDA has published a detailed Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue based products (HCT/Ps). As stated in the guidance, Regulatory Considerations for Human Cells,…

Read MoreFDA Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue-based products

AI powered device detecting SARS-CoV-2 within 20 secs currently under MHRA assessment

An Artificial Intelligence (AI) powered device able to detect SARS-CoV-2 (the virus that causes COVID-19) within 20 seconds is currently under UK MHRA assessment. What is the test called? The device is called SpectraLIT. Who has developed this test? The SpectraLIT device…

Read MoreAI powered device detecting SARS-CoV-2 within 20 secs currently under MHRA assessment

MHRA issues new guidance on Importing IMPs from countries on a list, to GB

The UK MHRA has issued new guidance on authorisations and procedures required to Import Investigational Medicinal Products (IMPs) from countries on a list, to Great Britain (GB). Information is also provided on the importation of authorised/unathorised: non-investigational medicinal products unmodified…

Read MoreMHRA issues new guidance on Importing IMPs from countries on a list, to GB

MHRA and Health Canada collaborate to publish guidance to improve patient safety in clinical trials through improved DSURs

The UK MHRA and Health Canada have collaborated to publish guidance to improve the safety of patients in clinical trials through improved quality of the periodic safety reports known as Development Safety Update Reports (DSURs). The guidance will improve the…

Read MoreMHRA and Health Canada collaborate to publish guidance to improve patient safety in clinical trials through improved DSURs